Animal models of anxiety: an ethological perspective
Tóm tắt
Từ khóa
Tài liệu tham khảo
File SE, 1992, Behavioural detection of anxiolytic action, 25
Green S, 1991, Animal models of anxiety, 21
Handley SL, 1991, Serotonin in animal models of anxiety: the importance of stimulus and response, 89
Lister RG, 1990, Ethologically-based animal models of anxiety disorders, Pharmacology and Therapeutics, 46, 321, 10.1016/0163-7258(90)90021-S
Rodgers RJ, 1994, The elevated plus-maze: pharmacology, methodology and ethology, 9
Stephens DN, 1991, Screening for anxiolytic drugs, 50
Treit D, 1994, Animal models of anxiety and anxiolytic drug action, 201
Griebel G, 1995, 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research, Pharmacology and Therapeutics, 65, 319, 10.1016/0163-7258(95)98597-J
Lader MH, 1991, Benzodiazepines and novel anxiolytics: clinical pharmacology, dependence and withdrawal, 343
Ashton H, 1994, Guidelines for the rational use of benzodiazepines, Drugs, 48, 25, 10.2165/00003495-199448010-00004
1994
Barrett JE, 1991, Animal behaviour models in the analysis and understanding of anxiolytic drugs acting at serotonin receptors, 37
Beck AT, 1985
Marks IM, 1987
Eysenck MW, 1991, Cognitive factors in clinical anxiety: potential relevance to therapy, 418
Willner P, 1991, Behavioural models in psychopharmacology, 3
Darwin CR, 1872
Blanchard DC, 1991, Risk assessment and animal models of anxiety, 117
Deakin JFW, 1991, 5-HT and mechanisms of defence, Journal of Psychopharmacology, 5, 305, 10.1177/026988119100500414
Beck AT, 1976
Clark DM, 1989, Anxiety states: panic and generalized anxiety, 52
Kidman A, 1989, Neurochemical and cognitive aspects of anxiety disorders, Progress in Neurobiology, 32, 391, 10.1016/0301-0082(89)90029-4
Depaulis A, 1991
Davis M, 1992, The role of the amygdala in fear and anxiety, Annual Review of Psychology, 15, 353
Edmunds M, 1974
Ratner SC, 1967, Comparative aspects of hypnosis, 550
Blanchard RJ, 1990, The characterization and modelling of antipredator defensive behavior, Neuroscience and Biobehavioral Reviews, 14, 491, 10.1016/S0149-7634(05)80069-7
Blanchard DC, 1990, Pharmacological and neural control of anti-predator defense in the rat, Aggressive Behavior, 16, 165, 10.1002/1098-2337(1990)16:3/4<165::AID-AB2480160304>3.0.CO;2-4
Pinel JPJ, 1983, The conditioned defensive burying paradigm and behavioral neuroscience, 212
DeVry J, 1993, Shock-induced ultrasonic vocalization in young adult rats: a novel model for testing putative anti-anxiety drugs, European Journal of Pharmacology, 249, 331, 10.1016/0014-2999(93)90530-U
Winslow JT, 1991, The infant rat separation paradigm: a novel test for novel anxiolytics, Trends in Pharmacological Sciences, 12, 402, 10.1016/0165-6147(91)90616-Z
Blanchard RJ, 1991, Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems, Physiology and Behavior, 50, 967, 10.1016/0031-9384(91)90423-L
Blanchard RJ, 1989, Anti-predator defensive behaviors in a visible burrow system, Journal of Comparative Psychology,, 103, 70, 10.1037/0735-7036.103.1.70
Blanchard RJ, 1995, Antipredator behavior of Swiss-Webster mice in a visible burrow system, Aggressive Behavior, 21, 123, 10.1002/1098-2337(1995)21:2<123::AID-AB2480210205>3.0.CO;2-E
Pinel JPJ, 1989, Adaptive interactions of rats with dangerous inanimate objects: support for a cognitive theory of defensive behavior, 137
Molewijk HE, 1995, The ambivalent behaviour 'stretched attend posture' as a paradigm to characterize anxiolytic drugs, Psychopharmacology, 121, 81, 10.1007/BF02245594
Kaesermann H-P, 1986, Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action, Psychopharmacology, 89, 31
Garbe CM, 1994, Effects of prior agonistic experience on risk assessment and approach behavior evoked by familiar and unfamiliar conspecific odors, Aggressive Behavior, 20, 143, 10.1002/1098-2337(1994)20:2<143::AID-AB2480200207>3.0.CO;2-D
Blanchard RJ, 1993, Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety, Behavioural Brain Research, 58, 155, 10.1016/0166-4328(93)90100-5
Hogg S, 1996, A review of the validity and variability of the elevated plus-maze as an animal model of anxiety, Pharmacology, Biochemistry and Behavior, 54, 21, 10.1016/0091-3057(95)02126-4
Montgomery KC, 1955, The relation between fear induced by novel stimulation and exploratory behavior, Journal of Comparative and Physiological Psychology, 48, 254, 10.1037/h0043788
Handley SL, 1984, Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour, Naunyn Schmiedeberg 's Archives of Pharmacology, 327, 1, 10.1007/BF00504983
Pellow S, 1985, Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, Journal of Neuroscience Methods, 14, 149, 10.1016/0165-0270(85)90031-7
Lister RG, 1987, The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology, 92, 180, 10.1007/BF00177912
Rex A, 1994, Effects of BOC-CCK-4 and L 365,260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus-maze, Neuropharmacology, 33, 559, 10.1016/0028-3908(94)90087-6
Hendrie CA, 1994, Effects of diazepam and buspirone in two models of anxiety in wild voles (Microtus socialis), Journal of Psychopharmacology, A46, 181
Yannielli PC, 1996, Daily rhythms in spontaneous and diazepam-induced anxiolysis in Syrian hamsters, Pharmacology, Biochemistry and Behavior, 54, 651, 10.1016/0091-3057(95)02106-X
Handley SL, 1993, Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors, Behavioural Brain Research, 58, 203, 10.1016/0166-4328(93)90104-X
Moser PC, 1989, An evaluation of the plus-maze test using the novel anxiolytic buspirone, Psychopharmacology, 99, 48, 10.1007/BF00634451
Dawson GR, 1995, Use of the elevated plus-maze in the search for novel anxiolytic agents, Trends in Pharmacological Sciences, 16, 33, 10.1016/S0165-6147(00)88973-7
Treit D, 1991, Anxiolytic effects of benzodiazepines and 5-HT1A agonists: animal models, 107
Rodgers RJ, 1991, A step in the right direction, Journal of Psychopharmacology, 5, 316, 10.1177/026988119100500415
Falter U, 1992, Resistance of baseline activity in the elevated plus-maze to exogenous influences, Behavioural Pharmacology, 3, 123, 10.1097/00008877-199204000-00004
Shepherd JK, 1992, Preliminary evaluation of an elevated 'zero-maze' as a model of anxiety in laboratory rats, Journal of Psychopharmacology, 6, A56, 223
Adamec RE, 1993, Lasting effects on rodent anxiety of a single exposure to a cat, Physiology and Behavior, 54, 101, 10.1016/0031-9384(93)90050-P
Lorenz K, 1973, The fashionable fallacy of dispensing with description, Naturwissenschaften, 60, 1, 10.1007/BF00591758
Tinbergen N, 1963, On the aims and methods of ethology, Zeitschrift für Tierpsychologie, 20, 410, 10.1111/j.1439-0310.1963.tb01161.x
Thorpe WH, 1979
Lee C, 1990, Antinociceptive effects of plus-maze exposure: influence of opiate receptor manipulations, Psychopharmacology, 102, 507, 10.1007/BF02247133
Rodgers RJ, 1992, Anxiogenic-like effects of fluprazine and eltoprazine in the mouse elevated plus-maze: profile comparisons with 8-OH-DPAT, CGS 12066B, TFMPP and mCPP, Behavioural Pharmacology, 3, 621, 10.1097/00008877-199212000-00009
Treit D, 1993, Anxiogenic stimuli in the elevated plus-maze, Pharmacology, Biochemistry and Behavior, 44, 463, 10.1016/0091-3057(93)90492-C
Rodgers RJ, 1995, Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze, Pharmacology, Biochemistry and Behavior, 52, 297, 10.1016/0091-3057(95)00138-M
Cruz APM, 1994, Ethopharmacological analysis of rat behavior on the elevated plus-maze, Pharmacology, Biochemistry and Behavior, 49, 171, 10.1016/0091-3057(94)90472-3
Fernandes C, 1996, The influence of open arm ledges and maze experience in the elevated plus-maze, Pharmacology, Biochemistry and Behavior, 54, 31, 10.1016/0091-3057(95)02171-X
McCreary AC, 1996, 5-HT system and anxiety: multiple mechanisms in the elevated plus-maze, Polish Journal of Pharmacology, 48, 1
Trullas R, 1993, Differences in fear-motivated behaviors among inbred mouse strains, Psychopharmacology, 111, 323, 10.1007/BF02244948
Rodgers RJ, 1993, Influence of social isolation, gender, strain and prior novelty on plus-maze behaviour in mice, Physiology and Behavior, 54, 729, 10.1016/0031-9384(93)90084-S
Holmes A, 1996, Factor analysis of behavioural responses to repeated testing in the plus-maze, Journal of Psychopharmacology,, 10, A47, 185
Blanchard RJ, 1989
Rodgers RJ, 1986, Acute non-opioid analgesia in defeated male mice, Physiology and Behavior, 36, 947, 10.1016/0031-9384(86)90458-0
Rodgers RJ, 1986, Resident's scent: a critical factor in acute analgesic reaction to defeat experience in male mice, Physiology and Behavior, 37, 317, 10.1016/0031-9384(86)90240-4
Rodgers RJ, 1987, Benzodiazepine ligands, nociception and defeat analgesia in male mice, Psychopharmacology, 91, 304, 10.1007/BF00518182
Rodgers RJ, 1988, Blockade of non-opioid analgesia in male mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands, Psychopharmacology, 96, 45, 10.1007/BF02431532
Rodgers RJ, 1989, Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone, Psychopharmacology, 99, 374, 10.1007/BF00445561
Rodgers RJ, 1992, Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147 and MDL 72699, Neuropharmacology, 31, 553, 10.1016/0028-3908(92)90187-T
Rodgers RJ, 1995, Neuropharmacological aspects of adaptive pain inhibition in murine 'victims' of aggression, Aggressive Behavior, 21, 29, 10.1002/1098-2337(1995)21:1<29::AID-AB2480210106>3.0.CO;2-A
Rodgers RJ, 1993, Anxiety enhancement in the elevated plus-maze by immediate prior exposure to social stressors, Physiology and Behavior, 53, 383, 10.1016/0031-9384(93)90222-2
Cole JC, 1993, An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro16-6028) in the murine elevated plus-maze, Behavioural Pharmacology, 4, 573
Johnson NJT, 1996, Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice, Psychopharmacology, 124, 355, 10.1007/BF02247441
Cole JC, 1995, Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze, Pharmacology, Biochemistry and Behavior, 52, 473, 10.1016/0091-3057(95)00163-Q
Rodgers RJ, 1996, Behavioural effects of subchronic chlordiazepoxide, maprotiline and fluvoxamine: II. The elevated plus-maze, Pharmacology, Biochemistry and Behavior
Shepherd JK, 1994, Behavioural and pharmacological characterization of the elevated zero-maze as an animal model of anxiety, Psychopharmacology, 116, 56, 10.1007/BF02244871
Griebel G, 1996, The use of the rat elevated plus-maze to discriminate non-selective and BZ-1(<FONT FACE="Symbol">w</font>1)-selective benzodiazepine receptor ligands, Psychopharmacology, 124, 245, 10.1007/BF02246664
Rodgers RJ, 1995, Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze, Pharmacology, Biochemistry and Behavior, 52, 805, 10.1016/0091-3057(95)00190-8
Dalvi A, 1996, GABAergic influences on plus-maze behaviour in mice, Psychopharmacology, 128, 380, 10.1007/s002130050148
Rodgers RJ, 1997, Anxiety, defence and the elevated plus-maze, Neuroscience and Biobehavioral Reviews, 10.1016/S0149-7634(96)00058-9
Lambert JJ, 1995, Neurosteroids and GABAA receptor function, Trends in Pharmacological Sciences, 16, 295, 10.1016/S0165-6147(00)89058-6
Rodgers RJ, 1996, Neuroactive steroid influences on anxiety, Behavioural Pharmacology, 7, 96, 10.1097/00008877-199605001-00219
Johnson NJT, 1996, Modulation of anxiety-related behaviour in mice by 5ß-dihydroprogesterone (5ß-DHP), Journal of Psychopharmacology, 10, A24, 93
Olivier B, 1995, Serotonin receptors and animal models of aggressive behavior, Pharmacopsychiatry, 28, 80, 10.1055/s-2007-979624
Kemble ED, 1987, Some fear-potentiating effects of fluprazine hydrochloride in mice, Aggressive Behavior, 13, 269, 10.1002/1098-2337(1987)13:5<269::AID-AB2480130504>3.0.CO;2-2
Cole JC, 1994, Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol, Psychopharmacology, 114, 288, 10.1007/BF02244851
Griebel G, 1996, Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test, Pharmacology, Biochemistry and Behavior
Rodgers RJ, 1994, Anti-anxiety and behavioural suppressant effects of the novel 5-HT1A receptor agonist, flesinoxan, Pharmacology, Biochemistry and Behavior, 48, 959, 10.1016/0091-3057(94)90205-4
Cao B-J, 1997, Different behavioural profiles of the R(+)- and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the murine elevated plus-maze, Behavioural Pharmacology
DeVry J, 1995, 5-HT1A receptor agonists: recent developments and controversial issues, Psychopharmacology, 121, 1, 10.1007/BF02245588
Fletcher A, 1993, Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents, Trends in Pharmacological Sciences, 14, 441, 10.1016/0165-6147(93)90185-M
Rodgers RJ, 1994, Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test, European Journal of Pharmacology, 261, 321, 10.1016/0014-2999(94)90124-4
Cao B-J, 1997, Anxiolytic-like profile of p-MPPI, a novel 5-HT1A receptor antagonist, in the murine elevated plus-maze, Psychopharmacology
Cao B-J, 1997, Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice: I. Pindolol enantiomers and pindobind 5-HT1A, Pharmacology, Biochemistry and Behavior
Cao B-J, 1997, Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice: II. WAY 100635, SDZ 216-525 and NAN-190, Pharmacology, Biochemistry and Behavior
File SE, 1996, Anxiolytic effects in the plus-maze of 5-HT1A receptor ligands in dorsal raphe and ventral hippocampus, Pharmacology, Biochemistry and Behavior, 54, 123, 10.1016/0091-3057(95)02108-6
Andrews N, 1994, 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours, respectively, European Journal of Pharmacology, 264, 259, 10.1016/0014-2999(94)00473-0
Hodges H, 1987, Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not discrimination, Psychopharmacology, 92, 491, 10.1007/BF00176484
Bill DJ, 1991, Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia, British Journal of Pharmacology, 103, 1857, 10.1111/j.1476-5381.1991.tb12342.x
Klein DF, 1981, Anxiety reconceptualized, 235
Nutt DJ, 1990, The pharmacology of human anxiety, Pharmacology and Therapeutics, 47, 233, 10.1016/0163-7258(90)90089-K
Ballenger JC, 1990
Den Boer JA, 1995, Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine, International Clinical Psychopharmacology, 9, 47, 10.1097/00004850-199501004-00007
Rodgers RJ, 1996, Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine: The elevated plus-maze, Pharmacology, Biochemistry and Behavior
File SE, 1991, 'One-trial tolerance' to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?, Psychopharmacology, 110, 240, 10.1007/BF02246980
Rodgers RJ, 1995, Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study, Journal of Psychopharmacology, 9, 38, 10.1177/026988119500900107
Rodgers RJ, 1995, Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289 in the elevated plus-maze test of anxiety in mice, Psychopharmacology, 117, 306, 10.1007/BF02246105
Rodgers RJ, 1995, The effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety, Behavioural Pharmacology, 6, 283, 10.1097/00008877-199504000-00009
Rodgers RJ, 1994, Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze, Pharmacology, Biochemistry and Behavior, 49, 985, 10.1016/0091-3057(94)90253-4
Cole JC, 1995, Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against <FONT FACE="Symbol">a</font>2-adrenoceptor mediation, Psychopharmacology, 118, 425, 10.1007/BF02245943
Rodgers RJ, 1996, Modulation of plus-maze behaviour in mice by the preferential D3 receptor agonist, 7-OH-DPAT, Pharmacology, Biochemistry and Behavior, 54, 79, 10.1016/0091-3057(95)02110-8
Costall B, 1987, Actions of sulpiride and tiapride in a simple model of anxiety in mice, Neuropharmacology, 26, 195, 10.1016/0028-3908(87)90209-7